Biogen | BIIB - Ebit

Cena Akcji
184.38
Dzienna Zmiana
-3.50 -1.86%
Miesięcznie
-2.54%
Rocznie
55.15%
Q2 Prognozy TE
180.43




Ebit Zmiana Data
AbbVie USD 5.81B 4.36B 2025-12
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Amgen USD 3.96B 464M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 3.74B 2.23B 2025-09
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12